Health Economic Aspects of Breast Cancer Treatment: The Compulsory Health Insurances' View | Zendy

Barbara Zimmer | Zendy; A. Heyll | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Health Economic Aspects of Breast Cancer Treatment: The Compulsory Health Insurances' View

Author(s) -

Barbara Zimmer,

A. Heyll

Publication year - 2013

Publication title -

breast care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.767

H-Index - 30

eISSN - 1661-3805

pISSN - 1661-3791

DOI - 10.1159/000346985

Subject(s) - medicine , breast cancer , cancer treatment , cancer , family medicine

Due to the impact of rising expenditures for the delivery of high-standard health care, further efforts supporting evidence-based, cost-efficient and patient-centered management in oncology are advised. This also concerns the treatment of patients with breast cancer. Reimbursement of diagnostic and/or therapeutic innovations in oncologic health care within the compulsory health insurances (CHIs) in Germany requests their evidence-based proof of benefit and medical need. Using selected examples in pharmacotherapy, recommendations to improve outpatient breast cancer care are discussed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research